Measles vaccine Market 2027 Type, Application | The Insight Partners

Measles vaccine Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ( Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) ); Application ( Children, Adults )

Report Code: TIPRE00010959 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Measles is a severe and infectious disease triggered by a virus. Early symptoms of the disease are fever, red eyes, runny nose, and cough. Later, red spots and tiny rashes are observed on skin. Measles is spread by a virus belonging to the paramyxovirus family, genus Morbillivirus. The diameter of virus is 120 nm to 250 nm. Measles only occurs in humans and not in animals. The measles virus first infects only the respiratory tract, then spreads throughout the body.

MARKET DYNAMICS

The measles vaccine market is driving due to the increasing number of incidences and prevalence of the disease and continuous efforts of the government and non-government agencies. Moreover, due to powerful regulations and patient safety the measles vaccine market is driving in the forecast period.

MARKET SCOPE

The "Measles vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of measles vaccine market with detailed market segmentation by of type and application. The measles vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in measles vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The measles vaccine market is segmented on the basis of type and application. Based on type, the market is segmented as mumps measles rubella vaccine, live (MMR-II) and mumps measles rubella and varicella virus vaccine (Proquad). On the basis of application, the market is categorized children and adult.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the measles vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The measles vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting measles vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the measles vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the measles vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from measles vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for measles vaccine in the global market. Below mentioned is the list of few companies engaged in the measles vaccine market.

The report also includes the profiles of key players in measles vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


    - Bavarian Nordic
    - CSL Limited
    - Emergent Biosolutions
    - GlaxoSmithKline plc
    - Johnson and Johnson
    - Merck & Co., Inc.
    - Novartis
    - Pfizer
    - Sanofi-Pasteur
    - Serum Institute of India


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Measles Vaccine Market - By Type
1.3.2 Measles Vaccine Market - By Application
1.3.3 Measles Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MEASLES VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MEASLES VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MEASLES VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MEASLES VACCINE - GLOBAL MARKET OVERVIEW
6.2. MEASLES VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MEASLES VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MUMPS MEASLES RUBELLA VACCINE
7.3.1. Overview
7.3.2. Mumps Measles Rubella Vaccine Market Forecast and Analysis
7.4. LIVE (MMR-II)
7.4.1. Overview
7.4.2. Live (MMR-II) Market Forecast and Analysis
7.5. MUMPS MEASLES RUBELLA AND VARICELLA VIRUS VACCINE (PROQUAD)
7.5.1. Overview
7.5.2. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Market Forecast and Analysis
8. MEASLES VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHILDREN
8.3.1. Overview
8.3.2. Children Market Forecast and Analysis
8.4. ADULTS
8.4.1. Overview
8.4.2. Adults Market Forecast and Analysis
9. MEASLES VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Measles Vaccine Market Overview
9.1.2 North America Measles Vaccine Market Forecasts and Analysis
9.1.3 North America Measles Vaccine Market Forecasts and Analysis - By Type
9.1.4 North America Measles Vaccine Market Forecasts and Analysis - By Application
9.1.5 North America Measles Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Measles Vaccine Market
9.1.5.1.1 United States Measles Vaccine Market by Type
9.1.5.1.2 United States Measles Vaccine Market by Application
9.1.5.2 Canada Measles Vaccine Market
9.1.5.2.1 Canada Measles Vaccine Market by Type
9.1.5.2.2 Canada Measles Vaccine Market by Application
9.1.5.3 Mexico Measles Vaccine Market
9.1.5.3.1 Mexico Measles Vaccine Market by Type
9.1.5.3.2 Mexico Measles Vaccine Market by Application
9.2. EUROPE
9.2.1 Europe Measles Vaccine Market Overview
9.2.2 Europe Measles Vaccine Market Forecasts and Analysis
9.2.3 Europe Measles Vaccine Market Forecasts and Analysis - By Type
9.2.4 Europe Measles Vaccine Market Forecasts and Analysis - By Application
9.2.5 Europe Measles Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Measles Vaccine Market
9.2.5.1.1 Germany Measles Vaccine Market by Type
9.2.5.1.2 Germany Measles Vaccine Market by Application
9.2.5.2 France Measles Vaccine Market
9.2.5.2.1 France Measles Vaccine Market by Type
9.2.5.2.2 France Measles Vaccine Market by Application
9.2.5.3 Italy Measles Vaccine Market
9.2.5.3.1 Italy Measles Vaccine Market by Type
9.2.5.3.2 Italy Measles Vaccine Market by Application
9.2.5.4 Spain Measles Vaccine Market
9.2.5.4.1 Spain Measles Vaccine Market by Type
9.2.5.4.2 Spain Measles Vaccine Market by Application
9.2.5.5 United Kingdom Measles Vaccine Market
9.2.5.5.1 United Kingdom Measles Vaccine Market by Type
9.2.5.5.2 United Kingdom Measles Vaccine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Measles Vaccine Market Overview
9.3.2 Asia-Pacific Measles Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Measles Vaccine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Measles Vaccine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Measles Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Measles Vaccine Market
9.3.5.1.1 Australia Measles Vaccine Market by Type
9.3.5.1.2 Australia Measles Vaccine Market by Application
9.3.5.2 China Measles Vaccine Market
9.3.5.2.1 China Measles Vaccine Market by Type
9.3.5.2.2 China Measles Vaccine Market by Application
9.3.5.3 India Measles Vaccine Market
9.3.5.3.1 India Measles Vaccine Market by Type
9.3.5.3.2 India Measles Vaccine Market by Application
9.3.5.4 Japan Measles Vaccine Market
9.3.5.4.1 Japan Measles Vaccine Market by Type
9.3.5.4.2 Japan Measles Vaccine Market by Application
9.3.5.5 South Korea Measles Vaccine Market
9.3.5.5.1 South Korea Measles Vaccine Market by Type
9.3.5.5.2 South Korea Measles Vaccine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Measles Vaccine Market Overview
9.4.2 Middle East and Africa Measles Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Measles Vaccine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Measles Vaccine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Measles Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Measles Vaccine Market
9.4.5.1.1 South Africa Measles Vaccine Market by Type
9.4.5.1.2 South Africa Measles Vaccine Market by Application
9.4.5.2 Saudi Arabia Measles Vaccine Market
9.4.5.2.1 Saudi Arabia Measles Vaccine Market by Type
9.4.5.2.2 Saudi Arabia Measles Vaccine Market by Application
9.4.5.3 U.A.E Measles Vaccine Market
9.4.5.3.1 U.A.E Measles Vaccine Market by Type
9.4.5.3.2 U.A.E Measles Vaccine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Measles Vaccine Market Overview
9.5.2 South and Central America Measles Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Measles Vaccine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Measles Vaccine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Measles Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Measles Vaccine Market
9.5.5.1.1 Brazil Measles Vaccine Market by Type
9.5.5.1.2 Brazil Measles Vaccine Market by Application
9.5.5.2 Argentina Measles Vaccine Market
9.5.5.2.1 Argentina Measles Vaccine Market by Type
9.5.5.2.2 Argentina Measles Vaccine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MEASLES VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MEASLES VACCINE MARKET, KEY COMPANY PROFILES
12.1. BAVARIAN NORDIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CSL LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EMERGENT BIOSOLUTIONS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI-PASTEUR
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SERUM INSTITUTE OF INDIA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bavarian Nordic
2. CSL Limited
3. Emergent Biosolutions
4. GlaxoSmithKline plc
5. Johnson and Johnson
6. Merck & Co., Inc.
7. Novartis
8. Pfizer
9. Sanofi-Pasteur
10. Serum Institute of India
TIPRE00010959
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking